Biogened S.A. (WSE:BGD)

Poland · Delayed Price · Currency is PLN

19.10

0.00 (0.00%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals		110.93M	95.56M	79.62M	65.32M	48.33M
Pharmaceuticals Growth		16.09%	20.02%	21.89%	35.15%	3.64%
Total		110.93M	95.56M	79.62M	65.32M	48.33M
Total Growth		16.09%	20.02%	21.89%	35.15%	3.64%

Revenue by Geography

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Export		50.37M	-	-	-	-
Poland		60.56M	-	-	-	-
Total		110.93M	-	-	-	-

Source: S&P Global Market Intelligence.